To evaluate the effects of Enoxaparine with doses of 20-40 mg a day given by subcutaneous injection for preventing venous thromboembolism (VTE) in 102 patients with acute internal diseases. Patients were undergone blood test, platelet count before and 3, 6, 9 and 14 days after treatment. Results: Enoxaparine with doses of 20-40 mg a day is effective in high-risk patients. Enoxaparine is safe, no serious side-effect, and could be a cost-effective drug for VTE prevention
Enoxaparin ; Blood Platelets ; Disease